Conference News
The Latest
Surgical strategy for perianal Crohn's: Lessons from TOpCLASS
-
by Doug Brunk
MRI-guided staging helps reshape surgical decision-making.
Creeping fat in Crohn's may turn harmful
-
by Doug Brunk
Even though it is common, the condition has not been studied much.
MRI-based standard may predict outcomes in perianal Crohn's
-
by Doug Brunk
The TopCLASS definition identifies healing based on three criteria.
Four reasons to add intestinal ultrasound to your practice
-
by Doug Brunk
“It's really made its way already into the mainstream of IBD care,” Dr. Rishika Chugh said.
Upadacitinib in pediatric IBD: 52-week results
-
by Doug Brunk
Response in those with ulcerative colitis was especially strong.
FMT improves IBD remission, meta-analysis suggests
-
by Doug Brunk
Researchers evaluated 7 trials involving 542 patients with UC or CD.
Positive trends in chronic HCV mortality
-
by Doug Brunk
“DAAs have revolutionized the management of HCV by making it a curable disease.”
Tirzepatide tops semaglutide for cardiometabolic protection in MASLD
-
by Doug Brunk
The study authors recommend prospective head-to-head trials to validate the findings.
ALD-related HCC mortality surges
-
by Doug Brunk
The findings underscore the urgent need for targeted prevention strategies among high-risk group.
New score challenges old predictors
-
by Kerri Miller
"MERAGE has superior performance for predicting return to drinking (RTD) compared to HRAR in AH."
ED drugs tied to lower gastric cancer risk
-
by Kerri Miller
Large retrospective study finds 30% reduction in gastric malignancy among men taking erectile dysfunction medications.
Gastric microbiome shifts track H pylori virulence
-
by Kerri Miller
Pathogenic bacterial genotypes correlate with distinct microbial communities; overall α-diversity is unchanged, but virulent strains show greater diversity within subgroups as atrophy progresses
Bariatric surgery vs GLP-1s: GERD risk
-
by Kerri Miller
Propensity-matched analysis of over 80,000 patients reveals bariatric surgery nearly doubles five-year esophageal complication rates compared with GLP-1 RA therapy.
Sarcopenia, thrombosis, and renal dysfunction dominate cirrhosis complication updates
-
by Kerri Miller
New diagnostic approaches and treatment controversies emerge for managing advanced liver disease complications.
Lower GI mistakes: Postop Crohn's, vaccine gaps, colonoscopy errors
-
by Kerri Miller
"There's no such thing as a routine colonoscopy. Every colonoscopy has a potential for mistakes."
Nutritional IBD screening tools ranked
-
by Kerri Miller
"MIRT might be the NSTs of choice to predict defined malnutrition and low-Fat Free Mass Index at 6 months follow-up in a cohort of inactive/mildly active IBD patients."
Do quadruple therapies beat triple for H. pylori?
-
by Kerri Miller
Concomitant and bismuth quadruple regimens provided substantially higher eradication rates than triple therapy without an adherence penalty.
Global IBD trial experts agree on steroid standards
-
by Teraya Smith
New guidance issued on how steroids should be managed in clinical trial settings.
Open vs robotic liver resections, study results
-
by Teraya Smith
Complication rates and hospital stays were analyzed across both surgical groups.
Advances in pancreaticobiliary disease interventions: More options and better outcomes
-
by Allison R. Schulman, MD, MPH